These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3306291)

  • 1. Use of Org OD 14 for the treatment of climacteric complaints.
    De Aloysio D; Fabiani AG; Mauloni M; Bottiglioni F
    Maturitas; 1987; Suppl 1():49-65. PubMed ID: 3306291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term placebo-controlled efficacy and safety study of Org OD 14 in climacteric women.
    Benedek-Jaszmann LJ
    Maturitas; 1987; Suppl 1():25-33. PubMed ID: 3306289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of Org OD 14 in the treatment of climacteric complaints.
    Trévoux R; Dieulangard P; Blum A
    Maturitas; 1983 Aug; 5(2):89-96. PubMed ID: 6633272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of a new steroid (Org OD 14) in the climacteric syndrome].
    Cittadini J; Ben J; Badano AR; Denari HJ; Quiroga S; Marcus AE; Schlaen I; Figueroa Casas PR
    Reproduccion; 1982; 6(2):69-79. PubMed ID: 6814971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placebo-controlled cross-over study of effects of Org OD 14 in menopausal women.
    Kicovic PM; Cortés-Prieto J; Luisi M; Milojevic S; Franchi F
    Reproduccion; 1982; 6(2):81-91. PubMed ID: 6754512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of climacteric complaints with Org OD 14: a comparative study with oestradiol valerate and placebo.
    Crona N; Samsioe G; Lindberg UB; Silfverstolpe G
    Maturitas; 1988 Mar; 9(4):303-8. PubMed ID: 3288845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical profile of Org OD 14.
    Tax L; Goorissen EM; Kicovic PM
    Maturitas; 1987; Suppl 1():3-13. PubMed ID: 3306290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind cross-over study with Org OD 14 and placebo in postmenopausal patients.
    Nevinny-Stickel J
    Arch Gynecol; 1983; 234(1):27-31. PubMed ID: 6660926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulation and fibrinolysis in post-menopausal women treated with Org OD 14.
    Cortes-Prieto J
    Maturitas; 1987; Suppl 1():67-72. PubMed ID: 3306292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A; Facchinetti F; Grasso A; Petraglia F; Campanini D; Genazzani AR
    Maturitas; 1986 Dec; 8(4):327-34. PubMed ID: 3033444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.
    Lindsay R; Hart DM; Kraszewski A
    Br Med J; 1980 May; 280(6225):1207-9. PubMed ID: 6992927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New steroid for the climacteric syndrome.
    Kicovic PM
    Minerva Endocrinol; 1989; 14(1):63-7. PubMed ID: 2659954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
    Hudita D; Posea C; Ceausu I; Rusu M
    Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A preliminary report on the treatment of climacteric symptoms with Org OD14].
    Wu YY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Sep; 28(9):539-41, 569-70. PubMed ID: 8313747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of Org OD 14 and 17 beta-oestradiol on bone and lipid metabolism in early post-menopausal women.
    Netelenbos JC; Siregar-Emck MT; Schot LP; van Ginkel FC; Lips P; Leeuwenkamp OR
    Maturitas; 1991 Jun; 13(2):137-49. PubMed ID: 1921737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of Org OD 14--a new steroidal therapy for climacteric symptoms.
    Hardiman P; Nihoyannopoulos P; Kicovic P; Ginsburg J
    Maturitas; 1991 Sep; 13(3):235-42. PubMed ID: 1943831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women.
    Genazzani AR; Petraglia F; Facchinetti F; Genazzani AD; Bergamaschi M; Grasso A; Volpe A
    Maturitas; 1987; Suppl 1():35-48. PubMed ID: 2957569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of the synthetic steroid Org OD14 on fibrinolysis and blood lipids in postmenopausal women.
    Walker ID; Davidson JF; Richards A; Yates R; McEwan HP
    Thromb Haemost; 1985 Jun; 53(3):303-5. PubMed ID: 3901389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Org OD 14 and the endometrium.
    Genazzani AR; Benedek-Jaszmann LJ; Hart DM; Andolsek L; Kicovic PM; Tax L
    Maturitas; 1991 Sep; 13(3):243-51. PubMed ID: 1943832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of Org OD 14 on lipid metabolism in post-menopausal women.
    Kloosterboer HJ; Benedek-Jaszmann LJ; Kicovic PM
    Maturitas; 1990 Apr; 12(1):37-42. PubMed ID: 2333035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.